Late morbidity and mortality in patients with hodgkin's lymphoma treated during adulthood Academic Article uri icon

Overview

MeSH Major

  • Cardiovascular Diseases
  • Endocrine System Diseases
  • Hodgkin Disease
  • Lung Diseases
  • Neoplasms, Second Primary

abstract

  • Among a large cohort of patients treated for HL with extensive follow-up, risk of late mortality from causes other than HL and prevalence of late medical morbidity are high. Guidelines for prevention, screening, and management of late effects in adult survivors of HL are needed.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1093/jnci/djv018

PubMed ID

  • 25717170

Additional Document Info

volume

  • 107

number

  • 4